Pharmabiz20m
EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer
EMA committee recommends approval of AstraZeneca’s Imfinzi in combo with chemotherapy to treat resectable non-small cell lung cancer ...
Pharmabiz3h
AbbVie and Gubra ink license agreement to develop an amylin analog for the treatment of obesity
North Chicago, Illinois Tuesday, March 4, 2025, 10:00 Hrs [IST] ...
Pharmabiz5h
SCDA asks NPPA to withdraw OM on e-pharmacies, seeks to publish price list in portal
Gireesh Babu, New Delhi Tuesday, March 4, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
Karnataka to come out with first-ever NSQ Recall Policy to ensure speedy withdrawal of substandard medicines
Our Bureau, Bengaluru Tuesday, March 4, 2025, 08:00 Hrs [IST] ...
Pharmabiz5h
DGFT notifies new SION for metronidazole gel to facilitate ease of doing business
DGFT notifies new SION for metronidazole gel to facilitate ease of doing business: Shardul Nautiyal, Mumbai Tuesday, March 4, 2025, 08:00 Hrs [IST] The Directorate General of Fore ...
Pharmabiz5h
COPD continues to pose significant challenges in India: Dr Sundeep Salvi
Dr Sundeep Salvi: Shardul Nautiyal, Mumbai Tuesday, March 4, 2025, 08:00 Hrs [IST] Chronic obstructive pulmonary disease (C ...
Pharmabiz20h
Onco-Innovations’ Inka Health AI-driven oncology study paves the way for new research in cancer
Onco-Innovations’ Inka Health AI-driven oncology study paves the way for new research in cancer: Vancouver, BC Monday, March 3, 2025, 17:00 Hrs [IST] Onco-Innovations Limited, a ...
Pharmabiz20h
IPA Mysuru with KSRPA, MCDRCA & JSS College of Pharmacy hold GST workshop for pharma retailers & distributors
IPA Mysuru with KSRPA, MCDRCA & JSS College of Pharmacy hold GST workshop for pharma retailers & distributors: Our Bureau, Bengaluru Monday, March 3, 2025, 16:30 Hrs [IST] The Ind ...
Pharmabiz19h
Belite Bio reports interim analysis results from phase 3 DRAGON trial of tinlarebant in adolescent Stargardt disease patients
Belite Bio reports interim analysis results from phase 3 DRAGON trial of tinlarebant in adolescent Stargardt disease patients: San Diego Monday, March 3, 2025, 18:00 Hrs [IST] Bel ...
Pharmabiz21h
SDM College of Pharmaceutical Sciences, Dharwad fosters importance of ideas and imagination in pharmacy career
SDM College of Pharmaceutical Sciences, Dharwad has noted that transformation in pharmacy career. The colleges sees that creativity, ideas, and imagination are the cornerstones of scholarly ...
Pharmabiz21h
Nxera Pharma inks agreement with Holling Bio-Pharma to commercialize daridorexant in Taiwan
Nxera Pharma inks agreement with Holling Bio-Pharma to commercialize daridorexant in Taiwan: Tokyo, Japan Monday, March 3, 2025, 16:00 Hrs [IST] Nxera Pharma Co., Ltd. announces t ...
Pharmabiz22h
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis
EMA committee recommends approval of AbbVie’s upadacitinib to treat adults with giant cell arteritis: North Chicago, Illinois Monday, March 3, 2025, 15:00 Hrs [IST] AbbVie annou ...